J Korean Med Sci. 2022 Nov 28;37(46):e329. English.
Published online Nov 08, 2022.
© 2022 The Korean Academy of Medical Sciences.
Case Report

Balloon Angioplasty for Hyperaldosteronism in Renal Artery Stenosis due to Takayasu Arteritis

Wooseong Jeong and Jinseok Kim
    • Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.
Received August 11, 2022; Accepted September 26, 2022.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Graphical Abstract

Takayasu’s arteritis is a chronic granulomatous vasculitis involving the aorta and its branches with characteristic clinical and angiographic features.1 A rare case of hyperaldosteronism due to renal artery stenosis in Takayasu's arteritis has been reported earlier.2, 3 We report a case in which hyperaldosteronism caused by renal artery stenosis due to Takayasu's arteritis was successfully treated with balloon angioplasty.

A 15-year-old male patient visited the hospital with intermittent abdominal pain and fever for 2 months. His blood pressure was 162/94 mmHg and body temperature, 38.2°C. There was no difference in blood pressure measured in both arms, and a bruit was auscultated in the abdomen. Left renal artery stenosis was observed on abdominal artery computed tomography angiography (Fig. 1A and B). Blood tests showed a white blood cell count of 8,190/μL, C-reactive protein level of 15.3 (0–0.3) mg/dL, erythrocyte sedimentation rate of 32 mm/hr, serum sodium level of 132 (136–145) mmol/L, and serum potassium level of 2.5 (3.5–5.1) mmol/L. Anti-nuclear antibody and anti-neutrophil cytoplasmic antibody tests performed to differentiate other diseases yielded negative results. Hyperaldosteronism was suspected due to hypertension, hypokalemia, and renal artery stenosis, and additional tests showed plasma renin activity of 8.42 (0.3–2.9) ng/mL/hr and an aldosterone level of 865.43 (1.2–34.0) pg/mL.

Fig. 1
Maximal intensity image (A) and volume-rendering image (B) of computed tomography angiography show focal stenosis (arrow) in the left renal artery proximal portion. (C) Abdominal aortography shows severe stenosis (more than 90%) in the proximal portion of the left renal artery. (D) Percutaneous Transluminal Angioplasty (PTA) was performed using a 4 mm × 4 cm and 6 mm × 4 cm balloon catheter. (E) After PTA, the inner diameter of the proximal renal artery was enlarged to about 80% of its original size.

After the diagnosis of Takayasu arteritis (Type IV), high-dose steroid treatment (prednisolone 1 mg/kg) was started, after which fever and inflammation (ESR; 16 mm/hr, CRP; 0.01 mg/dL) improved, but hypertension and hypokalemia persisted; thus, a calcium channel blocker and spironolactone were prescribed. However, as the hypokalemia persisted, balloon angioplasty was performed for left renal artery stenosis (Fig. 1C, D, and E). Balloon angioplasty was first performed using a 4 mm x 4 cm balloon catheter, and then performed again using a 6 mm x 4 cm balloon catheter. The blood pressure gradually improved to normal. And after 5 days of angioplasty, renin activity (1.65 ng/mL/hr), aldosterone (24.3 pg/mL), and potassium (3.7 mmol/L) levels showed improvement to the normal range. Therefore, the calcium channel blocker and spironolactone were discontinued. Blood tests performed 2 months after angioplasty showed that ESR, CRP, potassium, renin activity, and aldosterone were all within normal ranges. Antihypertensive drugs and spironolactone were not added again, and follow-up will be continued.

In patients with Takayasu arteritis, if renal artery stenosis is associated with hyperaldosteronism, balloon angioplasty may be a good option to treat hyperaldosteronism.

Ethics statement

This study was approved by the Institutional Review Board of Jeju National University Hospital (approval number 2022-08-009) with waived informed consent.

Notes

Disclosure:The authors have no potential conflicts of interest to disclose.

Author Contributions:

  • Conceptualization: Kim J.

  • Data curation: Jeong W.

  • Writing - original draft: Jeong W.

  • Writing - review & editing: Kim J.

ACKNOWLEDGEMENTS

This work was supported by the 2022 education, research, and student guidance grant funded by Jeju National University.

References

    1. Choi SJ, Koo HJ, Yang DH, Kang JW, Oh JS, Hong S, et al. Comparison of clinical, angiographic features and outcome in Takayasu’s arteritis and Behçet’s disease with arterial involvement. J Rheum Dis 2020;27(2):100–109.
    1. Borazan A, Sevindik OG, Solmaz D, Gulcu A, Cavdar C, Sifil A, et al. A rare cause of renovascular hypertension: Takayasu arteritis with only renal artery involvement. Ren Fail 2009;31(4):327–331.
    1. Zhao L, Xue J, Zhou Y, Dong X, Luo F, Jiang X, et al. Concurrent primary aldosteronism and renal artery stenosis: an overlooked condition inducing resistant hypertension. Front Cardiovasc Med 2022;9:818872

Metrics
Share
Figures

1 / 1

PERMALINK